Changes in Serum B-Cell Maturation Antigen Levels Rapidly Predict Progression Free Survival among Multiple Myeloma Patients undergoing New Treatment

MLA

Joshua Stern, et al. “Changes in Serum B-Cell Maturation Antigen Levels Rapidly Predict Progression Free Survival among Multiple Myeloma Patients Undergoing New Treatment.” Clinical Lymphoma Myeloma and Leukemia, vol. 19, Oct. 2019, pp. e173–74. EBSCOhost, https://doi.org/10.1016/j.clml.2019.09.290.

APA

Joshua Stern, Marsiye Emamy-Sadr, Saurabh Patil, Eric Souther, Tahmineh Safaie, Tanya M. Spektor, Camilia Soof, Cathy Wang, Mingjie Li, Eric Sanchez, James R. Berenson, Sean Bujarski, Ning Xu, Kyle Udd, Regina A. Swift, Ashkon Rahbari, & Haiming Chen. (2019). Changes in Serum B-Cell Maturation Antigen Levels Rapidly Predict Progression Free Survival among Multiple Myeloma Patients undergoing New Treatment. Clinical Lymphoma Myeloma and Leukemia, 19, e173–e174. https://doi.org/10.1016/j.clml.2019.09.290

Chicago

Joshua Stern, Marsiye Emamy-Sadr, Saurabh Patil, Eric Souther, Tahmineh Safaie, Tanya M. Spektor, Camilia Soof, et al. 2019. “Changes in Serum B-Cell Maturation Antigen Levels Rapidly Predict Progression Free Survival among Multiple Myeloma Patients Undergoing New Treatment.” Clinical Lymphoma Myeloma and Leukemia 19 (October): e173–74. doi:10.1016/j.clml.2019.09.290.